第一部分
1. Jennifer M, Edmonds, Martin S. TOONA SINENSIS. Benthan-Moxon Trust . 186-196. 1998.
2. Park JC, Yu YB, Lee JH, Chol JS, Ok KD. Phenolic Compounds from the Rachis of Cedrela sinensis. Kor J Pharmacogn. 27: 219-223, 1996.
3. Chin NY, Technician, Chang KH. Toona sinensis(A.Juss) Roem. In the illustrated medicinal plants of Taiwan, SMC publishing Inc Taiwan ROC. 1th: 131-132, 1995.
4. Edmonds JM, Staniforth M. Toona Sinensis (Meliaceae). Curtis’s Botanical Magazine. 15: 186-193, 1998.
5. 楊今詳。抗癌中草藥製劑。 渡假出版社有限公司 。p 165。1992。
6. 程劍華、 李以鑌。抗癌植物藥及其驗方。 江西科學出版社 。p608。1998。
7. Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant antivity. Lebensm-Wiss U Technol. 28：25-30, 1995.
8. Hsieh TJ, Chang FR, Wu YC. The constituents of Cananga odorata. Journal of the Chinese Chemical Society. 46：607-611, 1999.
9. Park JC, Yu YB, Lee JH, Choi JS, Ok KD. Phenolic compounds from the rachis of Cedrela sinensis. Kor J Pharmacogn.. 27：219-223, 1996.
10. Tsai IL, Jeng YF, Duh CY, Chen IS. Cytotoxic constituents from the leaves of Litsea akoensis. The Chinese Pharmaceutical Journal. 53：291-301, 2001.
11.賈宜琛。香椿保健活性成分之研究。92年度「保健食品研究開發」計畫成果發表會。P14-17。2003。
12.袁行修。香椿在婦科癌症上的應用。92年度「保健食品研究開發」計畫成果發表會。P178-186。2003。
13. Chang HC, Hung WC, Huang MS, Hsu HK. Extract from the leaves of Toona sinensis roemor exerts potent antiproliferative effect on human lung cancer cells. Am J Chin Med. 30：307-314, 2002.
14. 王珮憓。椿葉水萃取液在Alloxan所誘發的糖尿病鼠中降血糖作用之研究。高雄醫學大學醫學研究所碩士論文。 2000。15. 楊玲玲。香椿之抗發炎活性評估。92年度「保健食品研究開發」計畫成果發表會。P51-58。2003。
16. 林信伶。香椿之保肝、抗病毒、抗癌之藥理活性及細胞內NO/cGMP路徑之調節作用。高雄醫學大學醫學研究所碩士論文。2004。17. Yang FY. Study on the physiological function of Toona sinensis Roem in human spermatozoa.Master thesis in National Cheng Kung University , Taiwan, Tainan, ROC. 2003.
18. 林志隆。香椿對腹腔或骨盆腔癌症患者與化學治療引發的疼痛週邊神經病變的患者之止痛效果評估：動物與臨床試驗。93年度「保健食品研究開發」計畫成果發表會。P5-6。2004。
19. 鍾雲琴。 香椿抗癌有效成分之安全性評估。93年度「保健食品研究開發」計畫成果發表會。P7。2004。
20. Chen HY, Yen GC. Free radicals, antioxidant defenses and human health. Nutritional Sciences Journal. 23 : 105-121, 1998.
21. Imlay JA , Fridovich I . Assay of metabolic superoxide production in Escherchia coli. J Biol Chem. 266: 6957-6965, 1991.
22. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 329: 2002-2011, 1993.
23. Church DF, Prypr WA. Free radical chemistry of cigarette smoke andits toxicological implications. Environ health perspect. 64:111-126, 1985.
24. Halliwell B, Cutteridge JMC. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts . Arch. Biochem Biophys. 246：501-514, 1986.
25. Halliwell B. Oxidants and human disease: some new concepts . FASEB J. 1：358-364, 1987.
26. Hallzwell B, Gutteridge John MC. Free Radicals in Biology and Medicine, 1998 3th ed (Reprinted 2000) Oxford.
27. Morrissey PA, O'Brien N M. Dietary antioxidants in health and disease. Int Dairy Journal. 8：463-472, 1998.
28.丁克祥。SOD 生物醫學淺論。藝軒出版社。p204-228。1996。
29.增山吉成。自由基的陰謀。健康出版社。1997。
30. Halliwell B, Gutteridge JMC. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys. 246：501-514, 1986.
31.Giese J. Antioxidants: tools for preventing lipid oxidation. Food Technol. 50：73-78, 1996.
32. Tamura H, Kitta K, Shibamoto T. Formation of reactive aldehydes from fatty acids in a Fe2+/H2O2 oxidation system. J Agric Food Chem. 39：439-442, 1991.
33. Wang MY, Liehr JG. Lipid hydroperoxide-induced endogenous DNA adducts in hamsters; possible mechanism of lipid hydroperoxide-mediated carcinogenesis. Arch Biochem Biophys. 316：38-46, 1995.
34. Hamilton RJ, Kalu C, Prisk E, Pasley FB, Pierce H. Chemistry of free radicals in lipids. Food Chem. 60：193-199, 1997.
35. Dean RT, Gieseg R, Davies M J. Reactive species and their accumulation on radical damaged proteins. Trends Biochem Sci. 18：437-441, 1993.
36. Cerutti P. Oxy-radicals and cancer. The Lancet. 344：862-863, 1994.
37. Diplock AT, Rice Evan CA, Burdon RH. Is there a significant role for lipid peroxidant in the causation of malignancy and for antioxidants. 1994.
38.Machlin LJ, Bendich A. Free radical tissue damage : protective role of antioxidant nutrients. FASEB J. 441-445, 1987.
39. Nalini Jairath M. Coronary heart disease and risk factor management – a nursing perspective. 1999.
40. Schöneich C. Reactive oxygen species and biological aging: A mechanistic approach. Exp Gerontol. 34：19-34, 1999.
41. McCord JM. The evolution of free radicals and oxidative stress. Am J Med. 108：652-659, 2000.
42. Moskovitz J, Yim MB, Chock PB. Free radicals and disease. Arch Biochem Biophys. 397：354-359, 2002.
43. Aruoma OI , Halliwell B, Williamson G. In vitro methods for characterizing potential prooxidant and antioxidant actions of nonnutritive substances in plant foods.In"Antioxidant methodology in vivo and in vitro concepts. "ed. by O. I. Aruoma, and S. L. Cuppett, Ch. 10.p173-204.AOCS press, Champaign, Illinois. 1998.
44. Labuza TP. Kinetics of lipid oxidation in food. Crit Rev Food Technoi. 355-396, 1971.
45. Namiki M. Antioxidants/antimutagens in foods. Crit Rev Food Sci Nutr. 29：273-300, 1990.
46.Hertog MGL, Hollman PCH. Potential health effects of the dietary flavonol quercetin. Euro J Clin Nutr . 50：63, 1996.
47. Wang H, Cao G, Prior RL. Oxygen radical absorbing capacity of anthocyanins. J Agric Food Chem. 45：304, 1997.
48. Yen GC, Chen HY, Peng HH. Antioxidant and pro-oxidant effects of various tea extracts. J Agric Food Chem. 45: 30, 1997.
49. Grinberg LN, Newmark H, Kitrossky N, et al. Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochem Pharm .1997.
50. Rice-Evans CA, Miller NJ, Paganga G. Structure antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol Med. 20：933-956, 1996.
51.Hollman PCH, Hertog MGL, Katan MB. Analysis and health effects of flavonoids. Food Chem. 57：43-46, 1996.
52. Hertog MGL, Hollman PCH, Katan MB.Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands. J Agric Food Chem. 40：2379, 1992.
53. Crozier A, Lean ME, McDonald MS, Black C. Quentitative analysis of the flavonoid content of commercial tomatoes, onions, lettuce, and celery. J Agric Food Chem. 45：590-595, 1997.
54. Century B, Horwitt MK. Biological availability of various forms of vitamin E with respect to different induces of deficiency. Fed Proc Fed Am Soc Biol .24：906-911, 1965.
55. Papas AM. Oil-soluble antioxidants in foods. Toxicol and Health. 9：123-150, 1993.
56. Brown KM, Morrice PC, Duthie GG. Erythrocyte vitamin E andplasma ascorbate concentrations in relation to erythrocyte peroxidation in smokers and nonsmokers: dose response to vitamin E supplementation. Am J Clin Nutr. 65：496-502, 1997.
57. Ham AJM, Liebler DC. Antioxidant reactions of vitamin E in theperfused rat liver: product distribution and effect of dietary vitamin E
supplementation. Arch Biochem Biophys. 339：157-164, 1997.
58. Halliwell B, Murcia MA, Chirico S, Aruoma OI. Free Radicals and antioxidants in food and in vivo : What they do and how they work. Crit Rew Food Sci Nutr. 35:1＆2.7-20, 1995.
59. Mayes PA. Structure＆Function of the lipid-soluble vitamins.”In Harper，s biochemistry “Edited by Murry , R. K., Granner, D.K., Mayes,P.A.and Rodwell,V.W. Chapter 53.Appleton＆Lange,a Publishing Division of Prentice Hall. 588-599. 1993.
60. Moser U, Bendich A. Vitamin C. In: Machlin LJ editors. Handbook of vitamins: nutritional, biochemical, and clinical aspects. New York: Marcel Dekker, Inc. P195-232. 1991.
61. McCay PB. Vitamin E interactions with free radical and ascorbate.Ann Rev Nutr. 5：323-340, 1985.
62. Wefers H, Sies H. The protection by ascorbate and glutathione
against microsomal lipid peroxidation is dependent on vitamin E Eur J Biochem. 174：353-357, 1988.
63. Rojas C, Cadenas S, Monica LT, Rosa PC, Barja G. Increase in heart glutathione redox ratio and total antioxidant capacity and decrease inlipid peroxidation after Vitamin E dietary supplementation in guinea pigs. Free radic. Biol Med. 21：907-915, 1994.
64. Bonorden WR, Pariza MW. Antioxidant nutritions and protectionfrom free radicals. In: Kotsonis FN, Mackey M, Hjelle J editors.Nutritional toxicology. New York: Raven Press. P19-48.1994.
65. Pfander H. Carotenoids: an overview. Methods Enzymol .213：3-13, 1992.
66. Rouseff R, Nagy S. Health and nutritional benefits of citrus fruit components. Food Technol. 48：125-139, 1994.
67. Gordon HM. Dietary antioxidants in disease prevention. Nat Prod Rep. 265-273, 1996.
68.Bannister JV, Bannister WH, Rotilio G. Aspect of the structure,
function and applications of superoxide dismutase. Crit Rev Biochem Mol Biol. 22：111-118, 1987.
69. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem. 64：97-112, 1995.
70. White AC, Thannickal VJ, Fanburg BL. Glutathione deficiency in human disease. J Nutr Biochem. 5：218-226, 1994.
71. Skrzydlewska E, Farbiszewski R. Glutathione consumption and
inactivation of glutathione-related enzymes in livers, erythrocytes and
serum of rats after methanol intoxication. Arch Toxicol. 71：741-745, 1997.
72. Rosemeyer MA. The biochemistry of glucose-6-phosphate
dehydrogenase, 6-phosphogluconate dehydrogenase and glutathione
reductase. Cell Biochem Funct. 5：79-95, 1987.
73. Meister A. Glutathione. In: Arias IM, Jakoby EB, Popper H editors.The liver biology and pathobiology. New York: Raven Press. P401-419. 1988.
74. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 59：527-605, 1979.
75. Frei B. et al. Reactive oxygen species and antioxidant vitamins : mechanism of action. The American Journal of Medicine. 97(Supple 3A) : 3A-5S-12S, 1994.
76. Haffner JE, Repine JE. Pulmonary strategies of antioxidant defense.Am Rev Respir Dis. 140：531-554, 1989.
77.Reaven PD, Khouw A, Beltz WF, et al. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by b-carotene. Aterioscler Thromb Vasc Biol. 13：590, 1993.
78. Dieber-Rotheneder M, Puhl H, Waeg G, et al. Effect of oral supplementation with D-a-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res. 32：1325, 1991.
79. Ham AJM, Liebler DC. Antioxidant reactions of vitamin E in the perfused rat liver: product distribution and effect of dietary vitamin E supplementation. Arch Biochem Biophys. 339：157-164, 1997.
80. Bonorden WR, Pariza MW. Antioxidant nutritions and protection from free radicals. In: Kotsonis FN, Mackey M, Hjelle J editors.
Nutritional toxicology. New York: Raven Press. P19-48. 1994.
81. Kittss D. An evaluation of the multiple effects of the antioxidant vitamins. Trends in Plant Sci. & Tech.8: 198-203, 1997.
82.愛爾‧敏德爾 博士 原著 。劉幸珍 譯 。抗老化聖典。笛藤出版社。2001。
83. Kühnau Joachim. The Flavonoids. A class of semi-essential food components: their role in human nutrition. Wld Rev Nutr Diet. 24：117-191, 1976.
84. Sato M, Ramarathnam N, Suzuki Y, Ohkubo T, Takeuchi M,Ochi H. Varietal differences in the phenolic content and superoxide radical scavenging potential of wines from different sources. J Agric Food Chem. 44：37-41, 1996.
85. Reid TM, Loeb LA. Effect of DNA repair enzymes on mutagenesis by oxygen free radicals. Mutat Res. 289：181-186, 1993.
86. Stadtman ER, Oliver DN. Metal-catalyzed oxidation of protein.Physiological consequences. J Biol Chem. 266：2005-2008, 1991.
87. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants,and the degenerative diseases of aging. Proc Natl Acad Sci USA. 90：7915-7922, 1993.
88. Gutteridge, J. M. C. and Halliwell, B. Free radicals and antioxidants inageing and disease: fact or fantasy. In "Antioxidants in nutrition, health,and disease. " Ch. 6, p111-135. Oxford University press: Oxford New York Tokyo, 1994.
89. Cayuela-Martinez M. Oxygen free radicals and human disease. Biochimie. 77：147-161, 1995.
90. Cutler RG. Antioxidants and aging. Am J Clin Nutr. 53：373s-379s, 1991.
91. Aruoma OI. Extracts as antioxidant prophylactic agents. INFORM. 8：1236-1246, 1997.
92. Hertog MGL, Feskens EJM , Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 342：1007-1011, 1993a.
93. Hertog MGL, Hollman PCH, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer. 20：21-29, 1993b.
94. Chang HC, Lue SI, Hsu C, Hsu HK, Weng CF, Yuh-Lin Yu J. Effects of Chinese herbal prescriptions on copulatory activity in aged male rats: a preliminary study. American Journal of Chinese Medicine. 26：83-90, 1998.
95. Mitsuda H, Yasumoto K, Iwami K. Antioxidative action of indole compounds during the autoxidation of linoleic acid. Eiyo to Shokuryo. 19：210-214, 1966.
96. Shimada K, Fujikawa K, Yahara K, Nakamura T. Antioxidative properties of xanthan on the autoxidation of soybean oil in cyclodextrin emulsion. J Agric Food Chem. 40：945-948, 1992.
97. Robak J, Gryglewski IR. Flavonoids are scavengers of superoxide anions. Biochem Pharma. 37：837-841, 1988.
98. Oyaizu M. Antioxidative activity of browning products of glucosamine fractionated by organic solvent and thin-layer chromatography. Nippon Shokuhin kogyo Gakkaishi. 35：771-775, 1986.
99. Dinis TCP, Madeira VMC, Almeida LM. Action of phenolic derivatives (acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers. Arch Biochem Biophys. 315：161-169, 1994.
100. Laranjinha J, Alemeida L, Madeira V. Reactivity of dietary phenolic acids with peroxyl radicals: antioxidant activity upon low density lipoprotein peroxidation. Biochem Pharmacol. 48：487-494, 1994.
101. Morel I, Lescoat G, Cognel P, Sergent O, Pasdeloup N, Brissot P, Cillard P,Cillard J. Antioxidant and iron-chelating activities of the flavonoids catechin quercertin and diosmetin on iron loaded rat hepatocyte cultures. Biochem Pharmacol. 45：13-19, 1993.
102. Moran J F, Klucas RV, Grayer RJ, Abian J, Becana M. Complexes of iron with phenolic compounds form soybean nodules and other legume tissues: Prooxidant and antioxidant properties. Free Radic Biol Med. 22：861-870, 1997.
103. Laughton M J, Evan PJ, Moroney MA, Hoult JRS, Halliwell B. Inhibition of mammalian 5-lipoxygenase and cycloxygenase by flavonoids and phenolic dietary additives: relationship to antioxidant activity and iron-reducing ability. Biochem Pharmacol. 42：1673-1681,1991.
104.Duh PD, Yen GC. Antioxidative activity of three herbal water extracts. Food Chem. 60：639-645, 1997.
105.Tanaka T, Kojima T, Kawamori T, Wang A, Suzui M, Okamoto K , Mori H. Inhibition of 4-nitriquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis. 77：1321-1325 , 1993.
106.Emmons CL, Peterson DM, Paul GL. Antioxidant capability of oat (Avena sativa L.) extracts. 2. In vitro antioxidant activity and contents of phenolic and totol antioxidants. J Agric Food Chem. 47：4895-4898 , 1999.
107.Burns J, Gardner PT, O'Neil J, Crawford S, Morecroft I, McPhail D B, Lister C, Matthews D, MacLean MR, Lean MEJ, Duthie G G,Crozier A., 2000. Relationship among antioxidant activity, vasodilation capacity, and phenolic content of red wines. J Agric Food Chem. 48：220-230. Caccetta, R. A. A., Croft, K. D., Beilin, L. J. and Puddey, I. B, 2000.
108.Sanchez-Moreno C, Satue-Gracia MT, Frankel EN. Antioxidant activity of selected spanish wines in corn oil emulsions. J Agric Food Chem. 48：5581-5587, 2000.
109.Kalt W, Forney CF, Martin A, Prior RL. Antioxidant capacity, vitamin C, phenolics, and anthocyanins after fresh storage of small fruits. J Agric Food Chem. 47：4638-4644, 1999.
第二部分
1. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88：1785, 1991.
2. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid
peroxidation and antioxidants in oxidative modification of LDL. Free
Radic Biol Med. 13：341, 1992.
3. Navab M, Berliner JA, Watson AD, et al. The Yin and Yang of
oxidation in the development of the fatty streak: a review based on the 1994 George Lyman Duff Memorial Lecture. Aterioscler Throm Vasc
Biol. 16：831, 1996.
4. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in
atherogenensis. Free Radic Biol Med. 20：707, 1996.
5. Heinecke JW. Oxidants and antioxidants in the pathogenesis of
atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis. 141：1, 1998.
6. Sterinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity . N Engl J Med. 320：915, 1989.
7. Chisolm GM, Steinberg D. The oxidative modification hypothesis of
atherogenesis: an overview. Free Radic Biol Med . 28：1815, 2000.
8. Stocker R. Dietary and pharmacological antioxidants in atherosclerosis. Curr Opin Lipidol. 10：589, 1999.
9. Fruebis J, Steinberg D, Dresel HA, et al. A comparison of the
antiatherogenic effects of probucol and a structural analogue of
probucol in low density lipoprotein receptor-deficient rabbits. J Clin Invest. 94：392, 1994.
10. Fruebis J, Bird DA, Pattison J, et al. Extent of antioxidant protection of plasma LDL is not a receptor of the antiatherogenic effect of antioxidants. J Lipid Res. 38：2455, 1997.
11. Witting PK, Pettersson K, Östlund-Lindqvist A-M, et al. Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits. J Clin Invest . 104：213, 1999.
12. Witting PK, Pettersson K, Letters J, et al. Arterioscler Thromb Vasc Biol. 20：e26, 2000.
13. Alan Stevens, James Lowe原著。 許朝添 譯 。病理學（第二版） 。
藝軒圖書出版社。2002。
14. Ross R, Fuster V. The pathogenesis of atherosclerosis. In: Fuster V, Ross R, Topol EJ. Eds. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven Publishers. 25：441-460, 1996.
15. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362：801, 1993.
16. Sterinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 320：915, 1989.
17. Steinberg D. Oxidative modification of LDL abd atherogenesis.
Circulation. 95：1062, 1997.
18. Lusis AJ, Navab M. Lipoprotein oxidation and gene expression in the artery wall. Biochem Pharm. 46：2119, 1993.
19. Jialal I, Devaraj S. Low-density lipoprotien oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin Chem. 42：498, 1996.
20. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid
peroxidation in human blood plasma. Proc Natl Acad Sci USA. 85：
9748, 1988.
21.Heinecke JW, Rosen H, Chait A. Iron and copper promote
modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest. 74：1890, 1984.
22. Morel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth
muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 4：357, 1984.
23. Steinbrecher UP, Parthasarathy S, Leake DS, et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA. 81：3883, 1984.
24. Parthasarathy S, Printz DJ, Byod D, et al. Macrophage oxidation of lowdensity lipoprotein generates a modified form recognized by the scavengerreceptor. Arteriosclerosis. 6：505, 1986.
25. Hiramatsu K, Rosen H, Heinecke JW, et al. Superoxide initiates
oxidation of low density lipoprotein by human monocytes. Arteriosclerosis. 7：55, 1987.
26. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 232：34, 1986.
27. Halliwell B. Oxidationof low-density lipoprotein: questions of initiation, propagation, and the effect of antioxidants. Am J Clin Nutr. 61：670S, 1995.
28. Jialal I, Devaraj S. Low-density lipoprotien oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin Chem. 42：498, 1996.
29. 張為憲。食品化學。華香園出版社。P82。1997。
30. 張為憲。食品化學。華香園出版社。P156-157。1997。
31. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 232：34, 1986.
32. Halliwell B. Oxidationof low-density lipoprotein: questions of initiation, propagation, and the effect of antioxidants. Am J Clin Nutr. 61：670S, 1995.
33. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 272：20963, 1997.
34. Westhuyzen J. The oxidation hypothesis of atherosclerosis: an update. Annu Clin Lab Sci. 27：1, 1997.
35. Steinberg D. Oxidative modification of LDL abd atherogenesis. Circulation. 95：1062, 1997.
36. 張為憲。食品化學。華香園出版社。P89。1997。
37. Ferns GAA, Lamb DJ, Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis . 133：139, 1997.
38. Pfaffererott C, Meiselman HJ, Hochstein P.The effect of malonyldialdehyde on erythrocyte deformability. Blood. 59：12-5, 1982.
39. Ball K, Turner R. Smoking and the heart. the basis for action. Lancet. 2：822, 1974.
40. Stam H, Hulamann WC, Jongkind JF, et al. Endothelial lesions, dietary composition and lipid peroxidation. Eicosanoids. 2：1, 1989.
41. Gey KF, Moser UK, Jordan P, et al. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr. 57：787S, 1993.
42. Church DF, Pryor WA. Free radical chemistry of cigarette smoke and its toxicological implication. Environ Health Perspect . 64：111, 1985.
43. Wingard DL, Suarez L, Barrett-Connor E. The sex differential in mortality from all causes and ischaemic heart disease. Am J Epidermiol. 117：165, 1983.
44. Hulley S, Grady D, Bush T, et al. randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progrestin Replacement Study (HERS) Research Group. JAMA. 280：605. 1998.
45. Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement on the progression of coronary-artery arteriosclerosis. N Engl J Med. 343：522, 2000.
46. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 13：341-390, 1992.
47. Castaño G. et al. A long-term, open-lable study of the efficacy and tolerability of Policosanol in patients with high global coronary risk. Current Therapeutic Research. 60：379-391, 1999.
48. Hertog MGL, Hollman PCH. Potential health effects of the dietary flavonol quercetin. Euro J Clin Nutr. 50：63, 1996.
49. Wang H, Cao G, Prior RL. Oxygen radical absorbing capacity of anthocyanins. J Agric Food Chem. 45：304, 1997.
50. Yen GC, Chen HY, Peng HH. Antioxidant and pro-oxidant effects of various tea extracts. J Agric Food Chem. 45：30, 1997.
51. Grinberg LN, Newmark H, Kitrossky N, et al. Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochem Pharm. 54：973, 1997.
52.Jennifer M, Edmonds, Martin S. TOONA SINENSIS. Benthan-Moxon Trust. 186-196. 1998.
53.Park JC, Yu YB, Lee JH, Chol JS, Ok KD. Phenolic Compounds form the Rachis of Cedrela sinensis. Kor J Pharmacogn. 27：219-223, 1996.
54.Chin NY, Technician, Chang KH. Toona sinensis(A.Juss) Roem. In the illustrated medicinal plants of Taiwan, SMC publishing Inc Taiwan ROC. 1th：131-132, 1995.
55.Edmonds JM, Staniforth M.Toona Sinensis (Meliaceae). Curtis’s Botanical Magazine. 15：186-193, 1998.
56.王珮憓。椿葉水萃取液在Alloxan所誘發的糖尿病鼠中降血糖作用之研究。高雄醫學大學醫學研究所碩士論文。 2000。
57. Chang HC, Hung WC, Huang MS, Hsu HK. Extract from the leaves of Toona sinensis roemor exerts potent antiproliferative effect on human lung cancer cells. Am J Chin Med. 30：307-314, 2002.
58. 袁行修。香椿在婦科癌症上的應用。92年度「保健食品研究開發」計畫成果發表會：P178-186。
59.Hsieh TJ, Chang FR, Wu YC. The constituents of
Cananga odorata. Journal of the Chinese Chemical Society. 46：607-
611, 1999.
60.Park JC, Yu YB, Lee JH, Choi JS, Ok KD. Phenolic
compounds from the rachis of Cedrela sinensis. Korea Journal of
Pharmacognosy. 27：219-223, 1996.
61. Tsai IL, Jeng YF, Duh CY, Chen IS. Cytotoxic constituents from the leaves of Litsea akoensis. The Chinese Pharmaceutical Journal. 53：291-301, 2001.
62. Allain CC, Poon LS,Chen CSG, Richmond W, Fu PC. Enzyme Determination of Total Serum Cholesterol . Clin Chem. 20：470-475,1974.
63.Wallin B, Rosengren B, Shertzer HG, Camejo G. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for evaluation of antioxidants. Anal Biochem. 208：10-15, 1993.
64.Miura S, Watanabe J ,Tomita T, Sano M, Tomita I. The inhibitory
effect of tea polyphenol(flavon-3-ol derivatives) on Cu2＋mediated
oxidative modification of low-density lipoprotein. Biol PharmBull. 17：1567-1572, 1994.
65.Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidant and atherosclerotic
heart disease. N Engl J Med. 337：408-416, 1997.
66.Huang MT, Ferraro T. Polyphenolic compounds in food and cancer prevention: an overview. In: Ho C-T, Lee C-Y, Huang M-T, eds. Phenolic Compounds in Food and their Effects on Heath, vol 2. Antioxidants and cancer prevention. p8-32. Washington, DC: American Chemical Society. 1992.
67.Laranjinha J, Alemeida L, Madeira V. Reactivity of dietary phenolic acids with peroxyl radicals: antioxidant activity upon low density lipoprotein peroxidation. Biochem Pharmacol. 48：487-494, 1994.
68.Moran JF, Klucas RV, Grayer RJ, Abian J, Becana M. Complexes of iron with phenolic compounds form soybean nodules and other legume tissues: Prooxidant and antioxidant properties. Free Radic Biol Med. 22：861-870, 1997.
69.Sato M, Ramarathnam N, Suzuki Y, Ohkubo T, Takeuchi M, Ochi H. Varietal differences in the phenolic content and superoxide radical scavenging potential of wines from different sources. J Agric Food Chem. 44：37-41, 1996.
70.Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout O.Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 342：1007-1011 , 1993.
71.Meyer AS, Yi OS, Pearson DA, Waterhouse AL, Frankel EN. Inhibition of human low-density lipoprotein oxidation in relation to composition of phenolic antioxidants in grapes (Vitis vinifera). J Agric Food Chem. 45：1638-1643, 1997.
72.Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 341：454-457, 1993.
73.Frankel EN, Waterhouse AL, Teissedre PL. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J Agric Food Chem. 43：890-894, 1995.
74.Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr. 61：549-554,1995.
75.Abu-Amsha R, Croft KD, Puddey IB, Proudfoot JM, Beilin LJ. Phenolic content of various beverages determines the extent of inhibition of human serum and low density lipoprotein oxidation in vitro: identification and mechanism of some cinnamic derivatives from red wine. Clin Sci. 4：49-58, 1996.
第三部分
1.Carr Jacqueline H, Bernadette F Rodak. Clinical hematologyatlas. Philadelphia : Saunders. 1999.
2. Henderson LM, Chappel JB. NADPH oxidase of neutrophils.
Biochim Biophys Acta. 1273：87-107, 1996.
3. Alberts B, Bray D, Lewis J, Raff M, Roberts K,Watson J D.
Mol Biol Cell. 918-924. 1983.
4. Edwards SW. in Biochemistry and physiology of the neutrophil,
Cambridge University Press, London. 1994.
5. Kakizuka A, Miller WH, Jr Umesono K, Warrell RP, Jr Frankel SR, Murty VV, Dmitrovsky E, Evans RM. Chromosomal translocation t (15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell. 66：663-674, 1991.
6.Crans HN, Sakamoto KM. Transcription factors and translocations in lymphoid and myeloid leukemia. Leukemia. 15：313-331 , 2001.
7. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, Ca: a Cancer Journal for Clinicians. 48：6-29, 1998.
8. Stone RM, Mayer RJ. Treatment of the newly diagnosed adult with de novo acute myeloid leukemia. Hematol Oncol Clin N Am. 7：47-64, 1993.
9. Hoelzer DF. Therapy of the newly diagnosed adult with acute lymphoblastic leukemia. Hematol Oncol Clin N Am. 7：139-160, 1993.
10. Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. An Intern Med. 122：254-261, 1995.
11. Faguet GB. Chronic lymphocytic leukemia: an updated review. J Clin Oncol. 12：1974-1990, 1994.
12.Hengartner MO. The biochemistry of apoptosis. Nature. 407：770-775, 2000 .
13.Leonhard M, Gruber P, Chott PA. Mutations in apoptosis genes : a pathogenetic factor for human disease. Mutation Research. 488：211-231, 2001.
14.Shi Y. Mechanisms of caspase activation and inhibition during
apoptosis. Molecular Cell. 9：459-470, 2002.
15. Reed JC. Mechanisms of apoptosis avoidance in cancer Curr Opin Oncol. 11：68-75, 1999.
16. Martin SJ, Green DR. Apoptosis and cancer: the failure of controls on cell death and cell survival. Critical Reviews in Oncology/Hematology. 16：137-153, 1995.
17. Li N, Karin M. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proceedings of the National Academy of Sciences of the United States of America. 95：13012-7. 1998.
18. Mastrangelo AJ, Betenbaugh MJ. Overcoming apoptosis: new methods for improving protein-expression systems. Trends Biotechnol. 16：88-95, 1998.
19.Zornig M, Hueber AO, Evan G. Apoptosis regulators and their role in tumorigensis. Biochemica et Biophysica Acta. 1551：F1-F37 , 2001.
20.Inayat-Hussain SH, Mcguinness SM, Ross D. Caspase-dependent and independent mechanisms in apoptosis induced by hydroquinolone and catechol metabolites of remoxipride in HL-60 cells. Chem-Biol Interact. 128：51-63, 2000.
21.Robertson JD, Orrenius S, Zhivotovsky B. Reviews : nuclear events in apoptosis. Journal of Structure Biology. 129：346-358, 2000.
22.Yu XH, Perdue TD, Tones AM. Mitochondrial involvement in tracheary element programmed cell death. Cell Death and Differentiation. 9：189-198, 2002.
23. McConkey DJ. Biochemical determinants of apoptosis and necrosis. Toxicol Lett. 99：157-68,1998.
24. Wyllie A H. Apoptosis snd the regulation of cell numbers in normal and neoplastic tissues : an overview. Cancer metastasis rev. 11：95-103, 1992.
25.Elisabeth TT, Jong SD. Fas receptor-mediated apoptosis : a clinical application? J Pathol. 196：125-134, 2002.
26.Scaffidi C, Fulda S, Peter ME. Two CD 95 (Apo-1/Fus) sigualing pathways. The EMBO Tournal. 6：1675-1687 ,1998.
27. Lundberg AS, Weinberg RA. Control of the cell cycle and apoptosis.Eur J Cancer. 35：1886-94, 1999.
28. Wyllie A. Apoptosis Clues in the p53 murder mystery. Nature. 389：237-8, 1997.
29.Bates S, Vousden KH. p53 in signaling checlpoint arrest or apoptosis.Current Opinion in Genetics & Development. 6：12-8, 1996.
30.Flatt PM, Pietenpol JA. Mechanisms of cell-cycle checkpoints : at the crossroads of carcinogenesis and drug discovery. Drug Metab Rev. 32：283-305, 2000.
31. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the Bcl-2 gene in human follicular lymphoma. Science. 228：1440-3, 1985.
32.Antonsson B, Martinou JC. The Bcl-2 protein family.Experimental cell Research. 256：50-57, 2000.
33.Adams JM, Cory S. The Bcl-2 protein family : arbiters of cell surival. Science. 281：1322-1326, 1998.
34. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homology, Bax, that accelerates programmed cell death. Cell. 74：609-19, 1993.
35. Hengartner MO. The biochemistry of apoptosis. Nature. 407：770-6, 2000.
36. Toshiyuki N, Hong Z, Nobuhiro M, En L, Jin X, Bruce AY,Junying Y. Caspase-12 mediates endoplasmic reticulum specific apoptosis and cytotoxicity by amyloid. Nature. 403：98-103. 2000.
37. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376：37-43, 1995.
38. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275：1129-1132, 1997.
39.Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. [Review] [220 refs]. Crit rev immunol. 19：65, 1999.
40. Edmonds JM , Staniforth M. Toona sinensis: Meliaceae.
Curtis’s Botanical Magazine. 15：186-193, 1998.
41. Hsieh TJ, Chang FR, Wu YC. The constituents of Cananga odorata. Journal of the Chinese Chemical Society. 46：607-611, 1999.
42. Park JC, Yu YB, Lee JH, Choi JS, Ok KD. Phenolic compounds from the rachis of Cedrela sinensis. Korea Journal of Pharmacognosy. 27：219-223, 1996.
43. Tsai IL, Jeng YF, Duh CY, Chen IS. Cytotoxic constituents from the leaves of Litsea akoensis. The Chinese Pharmaceutical Journal. 53：291-301, 2001.
44. Laranjinha J, Alemeida L, Madeira V. Reactivity of dietary phenolic acids with peroxyl radicals: antioxidant activity upon low density lipoprotein peroxidation. Biochem Pharmacol. 48：487-494, 1994.
45. Huang MT, Ferraro T. Polyphenolic compounds in food and cancer prevention: an overview. In: Ho C-T, Lee C-Y, Huang M-T, eds. Phenolic Compounds in Food and their Effects on Heath, vol 2. Antioxidants and cancer prevention. p8-32. Washington, DC: American Chemical Society. 1992.
46.Wenzel U, Kuntz S, Brendel MD, Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res. 60:：3823-3831, 2000.
47.Mariadason JM, Corner GA , Augenlicht LH. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac and curcumin and implication for chemoprevention of colon cancer. Cancer Res. 60：4561-4572, 2000.
48. Chin NY, Technician, Chang KH. Toona sinensis(A.Juss) Roem. In the illustrated medicinal plants of Taiwan, SMC publishing Inc Taiwan ROC. 1th：131-132, 1995.
49. 袁行修。香椿在婦科癌症上的應用。92年度「保健食品研究開發」計畫成果發表會。P178-186。2003。
50. Jaffe EA, Nachmam RL, Becker CD, Minick CR . Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 52：2745-56, 1973.
51. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371：346-347, 1994.
52. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81：801-809, 1995.
53.Castedo M, Hirsch F, Susin SA, Zamzami N, Marchetti P, Macho A, Kroemer G. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. Journal of Immunology. 157：512-21, 1996.
54.Green DR, Reed JC. Mitochondria and apoptosis. Science. 281：1309-12, 1998.
55.Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A,
Haeffner A, Hirsch F, Geuskens M, Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. Journal of Experimental Medicine. 184：1155-60, 1996.
56.Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275：1129-32, 1997.
57.Zhivotovsky B, Orrenius S, Brustugun OT, Døskeland SO.Injected cytochrome c induces apoptosis. Nature. 391：449-50, 1998.
58.Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275：1132-6, 1997.
59.Zhan Q, Fan S, Bae I, Guillouf C, Liebermann DA, O’Connor PM, Fornace AJ Jr. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene. 9：3743-51, 1994.
60.Korsmeyer SJ. Bcl-2: an antidote to programmed cell death. Cancer Surveys. 15：105-18, 1992.
61.Korsmeyer SJ. Bcl-2: a repressor of lymphocyte death. Immunology Today. 13：285-8, 1992.
62.Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood. 80：879-86, 1992.
63.Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91：627-37, 1997.
64.Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell.75：229-40, 1993.
65.Veis DJ, Sentman CL, Bach EA, Korsmeyer SJ. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. Journal of Immunology. 151：2546-54, 1993.
66. Kaufman SN. Induction by endoucleolytic DNA cleavage in human actute myelogenous leukemia cells by etoposide, camptothecin and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 48：5870-5878, 1989.